FIRE1
PrivateLast Round
Series B
Jan 7, 2025
Total Funding Raised
$202.1M
Company Overview
FIRE1 operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Series B round in January 2025.
FIRE1 is a medical device company that develops remote monitoring systems for heart failure patients to improve clinical outcomes and reduce hospitalizations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials, Telemedicine
Business Model
B2B
Customer Profile
Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FIRE1 Comparables
Compare FIRE1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sensible Medical Innovations | 83% | |
| LifeWave Biomedical | 82% | |
| Acorai | 79% |
For institutional investors. Book with your work email.
FIRE1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 7, 2025 | ||||
| Series C Extension | Mar 15, 2023 | ||||
| Series C | Jan 30, 2018 | ||||
| Series B | Apr 12, 2016 | ||||
| Series A | Jan 9, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FIRE1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B |
| Gimv | Series C Extension, Series B, Series C |
| New Enterprise Associates | Series C Extension, Series A, Series B, Series C |
| Lightstone Ventures | Series C Extension, Series A, Series B, Series C |
| Andera Partners | Series B, Series C Extension |
| Gilde Healthcare | Series C Extension, Series B, Series C |
| Novo Holdings | Series B, Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Grew 16% QoQ, from 94 to 109 employees.
- Dec 2, 2025
Received two Red Dot design awards for its heart failure management system.
For institutional investors. Book with your work email.
FIRE1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FIRE1's valuation, stock price, and market status.
Is FIRE1 a public or private company?
FIRE1 is a private company.
What is the current stock price of FIRE1?
FIRE1 is a private company, so its shares have no public market price. Caplight tracks FIRE1's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FIRE1 worth (valuation)?
Valuation information for FIRE1 is not publicly available.
Can I buy FIRE1 stock?
FIRE1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FIRE1's last funding round?
FIRE1's most recent funding round was Series B on January 7, 2025.
Who are the main investors in FIRE1?
Key investors in FIRE1 include Andera Partners, Gilde Healthcare, Novo Holdings, Polaris Partners, Elevage Medical Technologies.
Will FIRE1 IPO soon?
No public IPO plans have been announced for FIRE1.
How can I track FIRE1 secondary market activity?
Caplight tracks bids, offers, and trades in FIRE1's shares on secondary markets.